DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Provera (Medroxyprogesterone) - Abdominal Pain - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Abdominal Pain (8)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Provera (Medroxyprogesterone) where reactions include abdominal pain. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Provera side effects in

Reported by a physician from United States on 2012-07-19

Patient:

Reactions: Abdominal Pain, Lymphadenopathy, Glossodynia, Osteomyelitis, Chronic Obstructive Pulmonary Disease, Colonic Polyp, Abdominal Discomfort, Oral Candidiasis, Pharyngeal Ulceration, Cellulitis, Peptic Ulcer, Oral Infection, Rectal Adenoma, Fungal Infection, Insomnia, Fistula Discharge, Tooth Abscess, Abdominal Pain Upper, Colitis Microscopic, Chest Pain, Blood Cholesterol Increased, Gastrooesophageal Reflux Disease, Drug Hypersensitivity, Haemorrhoids, Dental Caries, Musculoskeletal Pain, Appendix Disorder, Hyperlipidaemia, Anxiety, Osteonecrosis of JAW, Diarrhoea, Sepsis, Hypertension

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Actonel
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2008-04-20
    End date: 2010-01-01

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Start date: 2008-02-12
    End date: 2008-03-01

Fosamax
    Dosage: 70 mg, qw
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2001-01-29
    End date: 2008-03-20

Provera
    Administration route: Oral
    Start date: 2001-01-01



Possible Provera side effects in 58 year old female

Reported by a physician from United States on 2012-05-25

Patient: 58 year old female, weighing 66.0 kg (145.2 pounds)

Reactions: Abdominal Pain, Lymphadenopathy, Glossodynia, Osteomyelitis, Chronic Obstructive Pulmonary Disease, Abdominal Discomfort, Colonic Polyp, Oral Candidiasis, Pharyngeal Ulceration, Cellulitis, Peptic Ulcer, Oral Infection, Rectal Adenoma, Fungal Infection, Insomnia, Fistula Discharge, Tooth Abscess, Abdominal Pain Upper, Colitis Microscopic, Chest Pain, Blood Cholesterol Increased, Gastrooesophageal Reflux Disease, Haemorrhoids, Musculoskeletal Pain, Drug Hypersensitivity, Dental Caries, Appendix Disorder, Anxiety, Hyperlipidaemia, Diarrhoea, Osteonecrosis of JAW, Sepsis, Hypertension

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Fosamax
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2001-01-29
    End date: 2008-03-20

Provera
    Administration route: Oral
    Start date: 2001-01-01

Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2008-02-12
    End date: 2008-01-01

Actonel
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 2008-04-20
    End date: 2010-01-01



Possible Provera side effects in female

Reported by a individual with unspecified qualification from United States on 2012-01-10

Patient: female, weighing 67.1 kg (147.7 pounds)

Reactions: Abdominal Pain, Metaplasia, Breast Cancer in Situ, Mammogram Abnormal, Breast Cyst, Uterine Leiomyoma, Biliary Dilatation, Emotional Disorder, Breast Hyperplasia, Melanocytic Naevus, Proctalgia, Muscle Spasms, Back Pain, Breast Cancer, Postoperative Adhesion, Intervertebral Disc Protrusion, Pain in Extremity, Anaemia, Breast Mass, General Physical Health Deterioration, Osteopenia, Breast Calcifications, Micturition Urgency, Paraesthesia, Uterine Prolapse, Cerebral Small Vessel Ischaemic Disease, Dilatation Intrahepatic Duct Acquired, Insomnia, Osteoporosis, Pain, Rectal Haemorrhage, Breast Induration, Oral Herpes, Fall, Fibrocystic Breast Disease, Fibroadenoma of Breast, Aortic Arteriosclerosis, Intervertebral Disc Degeneration, Injury, Sinusitis, RIB Fracture, Breast Disorder, Biopsy Breast, Avulsion Fracture, Deformity, Anxiety, Atrophic Vulvovaginitis, Oral Pain, Presyncope, Spinal Disorder, Lymph Nodes Scan Abnormal, Arthritis

Drug(s) suspected as cause:
Hormones
    Indication: Menopause
    Start date: 1988-01-01
    End date: 1989-01-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-08-18
    End date: 1995-08-29

Prempro
    Dosage: .625/2.5 mg
    Administration route: Oral
    Indication: Menopause
    Start date: 1995-05-01
    End date: 1999-01-12

Premarin
    Dosage: 0.9 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1991-05-08
    End date: 1991-05-15

Premarin
    Dosage: 0.625 mg, unk
    Administration route: Oral
    Start date: 1991-05-16
    End date: 1995-08-29

Estraderm
    Dosage: 0.1 (units not spec.) 2x weekly
    Indication: Menopause
    Start date: 1991-08-18
    End date: 1991-10-01

Other drugs received by patient: Anusol HC; H2 Blocker ^ratiopharm^



Possible Provera side effects in female

Reported by a physician from United States on 2011-12-01

Patient: female, weighing 68.0 kg (149.6 pounds)

Reactions: Foot Deformity, Abdominal Pain, Endometrial Hyperplasia, Aortic Stenosis, Chronic Obstructive Pulmonary Disease, Vitamin B12 Deficiency, Dyspepsia, Uterine Leiomyoma, Breast Hyperplasia, Metabolic Disorder, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Ovarian Cyst, Coronary Artery Disease, Breast Mass, Cervical Dysplasia, Insomnia, Pelvic Pain, Fibrocystic Breast Disease, Fatigue, Chest Pain, Liver Function Test Abnormal, Dizziness, Depression, Gastrooesophageal Reflux Disease, Dyspnoea, Nausea, Amnesia, Rectocele, Dysuria, Visual Impairment

Drug(s) suspected as cause:
Premarin
    Dosage: 0.625 mg, unk
    Indication: Menopause
    Start date: 1990-11-26
    End date: 2000-11-01

Provera
    Dosage: 10 mg, unk
    Start date: 1990-11-26

Medroxyprogesterone
    Indication: Menopause
    Start date: 1991-01-01

Provera
    Dosage: 2.5 mg, unk
    End date: 2000-11-01

Ogen

Provera
    Indication: Menopause
    Start date: 1988-01-01
    End date: 1991-01-01

Premarin
    Start date: 1988-01-01
    End date: 1991-01-01

Prempro

Provera
    Start date: 1991-01-01

Premarin
    Administration route: Topical
    Indication: Menopause
    Start date: 1992-03-11
    End date: 1997-11-23

Hormones
    Administration route: Topical
    Indication: Menopause
    Start date: 1991-01-01

Climara

Estraderm
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1993-03-11

Estraderm
    Dosage: 0.05 mg, biw
    Start date: 1992-03-11
    End date: 1993-03-11

Cycrin
    Dosage: 2.5 mg, unk
    Indication: Menopause
    Start date: 1997-11-17
    End date: 1997-12-17

Other drugs received by patient: Calcium Carbonate; Fosamax; Plavix; Prednisone TAB; Tamoxifen Citrate; Zantac; Magnesium Sulfate; Tricor; Methotrexate; Fluconazole; Paxil; Naproxen (Aleve); Aspirin; Prevacid; Macrodantin; Folic Acid; Zoloft



Possible Provera side effects in female

Reported by a individual with unspecified qualification from United States on 2011-12-01

Patient: female, weighing 61.2 kg (134.7 pounds)

Reactions: Abdominal Pain, Muscle Atrophy, Breast Cancer in Situ, Loss of Consciousness, Breast Cancer Recurrent, Metastasis, Dyspepsia, Vulvovaginal Dryness, Mammogram, Breast Hyperplasia, Back Pain, Dyspareunia, Intervertebral Disc Protrusion, Dysphagia, Oestrogen Receptor Assay Negative, Breast Cancer Stage I, Ovarian Cyst, Breast Cancer Stage III, Breast Mass, Renal Cyst, Osteopenia, Colitis, Breast Necrosis, Excessive Granulation Tissue, Confusional State, Application Site Reaction, Head Injury, Osteoporosis, Pain, Fall, Weight Increased, Fibrocystic Breast Disease, Chest Pain, Intervertebral Disc Degeneration, Injury, Oestrogen Receptor Assay Positive, Depression, Hallucination, Gastrooesophageal Reflux Disease, Progesterone Receptor Assay Negative, Scoliosis, Bone Giant Cell Tumour, Radius Fracture, Anxiety, Atrophic Vulvovaginitis, Spinal Osteoarthritis, Arthritis, Physical Disability, Breast Fibrosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Premarin
    Dosage: 0.625 mg, unk
    Administration route: Oral
    Start date: 1992-10-01
    End date: 1997-07-01

Provera
    Dosage: 5/2.5 mg day 1-14
    Administration route: Oral
    Start date: 1992-10-01
    End date: 1997-07-01

Ogen
    Start date: 1992-06-01
    End date: 1993-04-01

Estraderm
    Dosage: 0.05 mg, 2x/wk
    Start date: 1995-09-01
    End date: 1995-11-01

Prempro
    Dosage: 625/2.5 mg
    Indication: Menopausal Symptoms
    Start date: 1996-06-01
    End date: 1996-06-01

Premarin

Other drugs received by patient: Multivitamins, Combinations; Xanax; Prozac; Evista



Possible Provera side effects in female

Reported by a lawyer from United States on 2011-11-29

Patient: female, weighing 68.0 kg (149.6 pounds)

Reactions: Abdominal Pain, Aortic Stenosis, Pelvic Pain, Chronic Obstructive Pulmonary Disease, Fatigue, Fibrocystic Breast Disease, Dyspepsia, Uterine Leiomyoma, Chest Pain, Liver Function Test Abnormal, Dizziness, Breast Hyperplasia, Depression, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Nausea, Breast Mass, Ovarian Cyst, Cervical Dysplasia, Amnesia, Rectocele, Visual Impairment

Drug(s) suspected as cause:
Provera
    Dosage: 10 mg, unk
    Start date: 1990-11-26

Cycrin
    Dosage: 2.5 mg, unk
    Indication: Menopause
    Start date: 1997-11-17
    End date: 1997-12-17

Prempro

Hormones
    Administration route: Topical
    Indication: Menopause
    Start date: 1991-01-01

Ogen

Provera
    Start date: 1991-01-01

Premarin
    Dosage: 0.625 mg, unk
    Indication: Menopause
    Start date: 1990-11-26
    End date: 2000-11-01

Premarin
    Administration route: Topical
    Indication: Menopause
    Start date: 1992-03-11
    End date: 1997-11-23

Estraderm
    Dosage: 0.05 mg, biw
    Start date: 1992-03-11
    End date: 1993-03-11

Premarin
    Start date: 1988-01-01
    End date: 1991-01-01

Medroxyprogesterone
    Indication: Menopause
    Start date: 1991-01-01

Provera
    Indication: Menopause
    Start date: 1988-01-01
    End date: 1991-01-01

Provera
    Dosage: 2.5 mg, unk
    End date: 2000-11-01

Climara

Estraderm
    Indication: Menopause
    Start date: 1991-01-01
    End date: 1993-03-11

Other drugs received by patient: Methotrexate; Aspirin; Naproxen (Aleve); Magnesium Sulfate; Plavix; Macrodantin; Tamoxifen Citrate; Zantac; Prevacid; Fluconazole; Paxil; Prednisone; Folic Acid; Zoloft; Calcium Carbonate; Fosamax; Tricor



Possible Provera side effects in female

Reported by a lawyer from United States on 2011-11-28

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Abdominal Pain, Pulmonary Hypertension, Lymphocyte Count Increased, FAT Embolism, Myocardial Ischaemia, Endoscopy Upper Gastrointestinal Tract, Chronic Obstructive Pulmonary Disease, Lumbar Spinal Stenosis, Metastatic Lymphoma, Hypoxia, Back Pain, Pain in Extremity, Breast Cancer Stage I, Breast Mass, Renal Cyst, Osteopenia, Hepatic Steatosis, Breast Cancer Stage II, Bone Densitometry, Breast Necrosis, Ultrasound Abdomen Abnormal, Pleural Fibrosis, Dyslipidaemia, Osteoporosis, Aortic Aneurysm, Gastritis, Dyspnoea Exertional, Interstitial Lung Disease, Basal Cell Carcinoma, Blood Cholesterol Increased, Malignant Melanoma, Oestrogen Receptor Assay Positive, Myocardial Infarction, Emphysema, Scoliosis, Dyspnoea, Nausea, Squamous Cell Carcinoma, Spondylolisthesis, Peripheral Vascular Disorder, Progesterone Receptor Assay Positive, Pulmonary Fibrosis, Osteoarthritis, Cardiac Failure, Nuclear Magnetic Resonance Imaging Abnormal, Spinal Osteoarthritis, Hypertension

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Medroxyprogesterone
    Indication: Hormone Replacement Therapy
    Start date: 1997-01-01
    End date: 2002-01-01

Prempro
    Dosage: .625/2.5 mg
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 1998-12-01
    End date: 2002-10-01

Estraderm
    Dosage: 0.05 mg, unk
    Indication: Osteoporosis Prophylaxis
    Start date: 1992-01-01
    End date: 1998-12-01

Provera
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Osteoporosis Prophylaxis
    Start date: 1992-01-01
    End date: 1998-12-01

Other drugs received by patient: Letairis; Calcium; Coumadin; Zocor; Advair Diskus 100 / 50; Boniva; Hydrochlorothiazide; Cozaar; Vitamin D; Spiriva; Celebrex; Viagra; Fosamax



Possible Provera side effects in female

Reported by a consumer/non-health professional from United States on 2011-10-24

Patient: female, weighing 68.0 kg (149.7 pounds)

Reactions: Abdominal Pain, Lymphadenopathy, Metastases To Liver, Headache, Malaise, Hot Flush, Uterine Leiomyoma, Pneumothorax, Hypoxia, Hepatic Cirrhosis, Muscle Spasms, Back Pain, Intervertebral Disc Protrusion, Pneumonia, Ovarian Cyst, Musculoskeletal Discomfort, Osteopenia, Breast Calcifications, Diverticulum Intestinal, Breast Cancer Stage II, Insomnia, Dermal Cyst, Breast Necrosis, Portal Hypertension, General Physical Condition Abnormal, Impaired Work Ability, Pain, Bone Pain, Pelvic Pain, Pleural Effusion, Depression, Cholecystitis, Splenomegaly, Adrenal Mass, Blood Pressure Increased, Polyp, Dyspnoea, Lung Neoplasm, Rash, Deformity, Ascites, Osteoarthritis, Anxiety, Device Failure, Atrophic Vulvovaginitis, Arthralgia, Leukocytosis

Drug(s) suspected as cause:
Estraderm
    Dosage: .05 mg, qw2
    Indication: Menopause
    Start date: 1999-01-01
    End date: 2000-01-01

Premarin
    Indication: Hormone Replacement Therapy

Cycrin
    Dosage: 2.5 mg, unk
    Administration route: Oral
    Indication: Menopause
    Start date: 1999-01-01
    End date: 2000-01-01

Estrostep
    Dosage: unk
    Indication: Menopause
    End date: 2001-01-01

Prempro
    Dosage: .625/2.5 mg
    Administration route: Oral
    Indication: Menopause
    Start date: 2000-01-01
    End date: 2002-01-01

Medroxyprogesterone Acetate
    Indication: Menopause

Provera
    Indication: Hormone Replacement Therapy

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017